Beyond Rheumatoid Arthritis Evaluation: What are We Missing?
Autor: | Espinoza G; Rheumatology Department - Universidad Espiritu Santo, Samborondon, Ecuador., Maldonado G; Internal Medicine Department - Loyola MacNeal Hospital, Berwyn, United States of America., Narvaez J; Rheumatology Department - Universidad Espiritu Santo, Samborondon, Ecuador., Guerrero R; Rheumatology Department - Universidad Espiritu Santo, Samborondon, Ecuador., Citera G; Rheumatology Department - Instituto Nacional de Rehabilitación Psicofísica, Buenos Aires, Argentina., Rios C; Rheumatology Department - Universidad Espiritu Santo, Samborondon, Ecuador. |
---|---|
Jazyk: | angličtina |
Zdroj: | Open access rheumatology : research and reviews [Open Access Rheumatol] 2021 Mar 25; Vol. 13, pp. 45-55. Date of Electronic Publication: 2021 Mar 25 (Print Publication: 2021). |
DOI: | 10.2147/OARRR.S298393 |
Abstrakt: | Rheumatoid Arthritis (RA) is a chronic inflammatory autoimmune systemic disease that preferentially affects small and large joints with a progressive course and can become deforming and disabling. In recent years, much progress has been made in the evaluation of inflammation and disease activity, however, there are other factors that have a high impact on the quality of life of these patients, such as depression, anxiety, fatigue, sleep disorders, suicidal behavior, fibromyalgia, sexual activity, sarcopenia, frailty, cachexia and obesity that are not always evaluated by rheumatologists. This review shows that the evaluation and timely detection of these aspects in patients with RA could interfere with the prognosis and improve their quality of life. Competing Interests: Dr Gustavo Citera report grants, personal fees from Pfizer, during the conduct of the study; grants, personal fees from Pfizer, outside the submitted work. The authors report no other conflicts of interests in this work. (© 2021 Espinoza et al.) |
Databáze: | MEDLINE |
Externí odkaz: |